Overview
Alomone Labs is pleased to offer the GABA Transporter Antibody Explorer Kit (#AK-435). The Explorer Kit contains GABA transporter antibodies, ideal for screening purposes.
Compounds
Product Name | Cat # | Size |
---|---|---|
Anti-BGT-1 (SLC6A12) Antibody |
AGT-004 | 1 x 50 µl |
BGT-1/SLC6A12 Blocking Peptide |
BLP-GT004 | 1 x 40 µg |
Anti-GABA Transporter 1 (GAT-1) (extracellular) Antibody |
AGT-001 | 1 x 50 µl |
GABA Transporter 1/GAT-1 (extracellular) Blocking Peptide |
BLP-GT001 | 1 x 40 µg |
Anti-GABA Transporter 2 (GAT-2) Antibody |
AGT-002 | 1 x 50 µl |
GABA Transporter 2/GAT-2 Blocking Peptide |
BLP-GT002 | 1 x 40 µg |
Anti-GABA Transporter 3 (GAT-3) Antibody |
AGT-003 | 1 x 50 µl |
GABA Transporter 3/GAT-3 Blocking Peptide |
BLP-GT003 | 1 x 40 µg |
Anti-Vesicular GABA Transporter (VGAT) Antibody |
AGT-005 | 1 x 50 µl |
Vesicular GABA Transporter/VGAT Blocking Peptide |
BLP-GT005 | 1 x 40 µg |
Guinea pig Anti-Vesicular GABA Transporter (VGAT) Antibody |
AGT-005-GP | 1 x 50 µl |
Vesicular GABA Transporter/VGAT Blocking Peptide |
BLP-GT005 | 1 x 40 µg |
Anti-Taurine Transporter (SLC6A6) Antibody |
AGT-006 | 1 x 50 µl |
Taurine Transporter/SLC6A6 Blocking Peptide |
BLP-GT006 | 1 x 40 µg |
Scientific Background
γ-aminobutiric acid (GABA) is the major inhibitory neurotransmitter in the mammalian central nervous system. Transmission via GABA can be halted by its reuptake through GABA transporters (GATs). These membrane proteins belong to the super family of slc6 genes which encode transporters responsible for the uptake of dopamine, serotonin, norepinephrine, glycine and GABA in a Na+-dependent manner1,2.
To date, four GATs have been identified: GAT-1, GAT-2, GAT-3 and BGT-1. Like all members of the slc6 family, they have twelve transmembrane domains and short intracellular N- and C-termini1. GATs couple the transport of one GABA molecule to 2Na+ ions and one Cl- ion3. GAT-1 activity can be regulated at the level of its plasma membrane expression which is in part regulated by its trafficking via phosphorylation of residues in intracellular loops1.
- Gonzalez-Burgos, G. (2010) Adv. Pharmacol. 58, 175.
- Gether, U. et al. (2006) Trends Pharmacol. Sci. 27, 375.
- Meinild, A.K. et al. (2009) J. Biol. Chem. 284, 16226.